• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$0.24 $0.00 (-0.25%)

REAL-TIME: Last trade at

CARDIUM THERAPEUTICS, INC

AMEX:CXM

Jump to this page for:

Related Resources

Sachs Associates to host a forum

5/21/2012 by Theflyonthewall.com

Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences

5/17/2012 by PR Newswire

Cardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene Delivery In Late-Breaking Presentation at 2012 American Society of Gene & Cell Therapy Meeting

5/16/2012 by PR Newswire

Cardium Therapeutics (CXM) Enters Excellagen Agreement with Angel Biomedical

5/15/2012 by StreetInsider.com

Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion

5/15/2012 by PR Newswire

Cardium Presents First Quarter 2012 Financial Results and Recent Developments

5/15/2012 by PR Newswire

Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care

4/19/2012 by PR Newswire

Smith Medical Partners announces logistics agreement with Cardium

4/2/2012 by Theflyonthewall.com

Smith Medical Partners Announces Logistics Agreement for Cardium's National Distribution of Excellagen™

4/2/2012 by PR Newswire

Cardium Announces U.S. Market Introduction Of Excellagen?

4/1/2012 by Biocompare

Cardium Presents Fourth Quarter and Year-End 2011 Financial Results and Recent Developments

3/30/2012 by PR Newswire

Cardium Therapeutics announces U.S. market introduction of Excellagen

3/30/2012 by Theflyonthewall.com

Cardium Announces U.S. Market Introduction of Excellagen™

3/30/2012 by PR Newswire

RevNutrition.com to Carry MedPodium Nutra-Apps® Brand

3/21/2012 by PR Newswire

Cardium Therapeutics initiates Generx phase 3 clinical registration study

3/20/2012 by Theflyonthewall.com

Cardium Initiates Generx® Phase 3 Clinical Registration Study

3/20/2012 by PR Newswire

Cardium Partners With NPI, InHealth Media

3/14/2012 by PR Newswire

Investor Optimism in Biotech Skyrockets - Cardium Therapeutics and Oncothyreon on the Upswing

2/23/2012 by Marketwire

Cardium Therapeutics Gets $5M Boost From Stock Sale

2/21/2012 by San Diego Business Journal

Cardium Therapeutics announces closing of $5M equity financing

2/16/2012 by Theflyonthewall.com

Cardium Announces Closing of $5.0 Million Equity Financing

2/16/2012 by PR Newswire

Cardium Therapeutics announces $5M financing with institutional investors

2/13/2012 by Theflyonthewall.com

Cardium Announces $5.0 Million Financing With Institutional Investors

2/13/2012 by PR Newswire

Cardium Presents New Generx Findings at 2012 Annual Gene and Cell Therapy Forum

1/30/2012 by PR Newswire

Biotechnology Industry on the Upswing - BioSante and Cardium Therapeutics Look to Rally

1/17/2012 by Marketwire

Cardium Therapeutics regains listing compliance with NYSE Amex

1/6/2012 by Theflyonthewall.com

Cardium Regains Listing Compliance With NYSE Amex

1/6/2012 by PR Newswire

Cardium Announces First International Marketing And Distribution Agreement For Commercialization Of Excellagen? In South Korea

1/5/2012 by Biocompare

Cardium: 1st int'l marketing, distribution agreement for Excellage in So. Korea

1/5/2012 by Theflyonthewall.com

Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea

1/5/2012 by PR Newswire

Cardium to Present at Upcoming Investor Conferences

1/4/2012 by PR Newswire

Cardium reports on renewed compliance with NYSE Amex listing guidelines

1/3/2012 by Theflyonthewall.com

Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines

1/3/2012 by PR Newswire

Cardium Therapeutics (CXM) Enters Into Cross-Strategic Equity Investment Partnership with SourceOne Global Partners

12/21/2011 by StreetInsider.com

Cardium Therapeutics enters cross-strategic equity investment with SourceOne

12/21/2011 by Theflyonthewall.com

Cardium and SourceOne Global Partners Enter Into Cross-Strategic Equity Investment with Plans to Jointly Develop Nutritional Supplements and Medical Foods

12/21/2011 by PR Newswire

Cardium Announces MedPodium Neo-Energy™ and Neo-Carb Bloc™

12/13/2011 by PR Newswire

Cardium Therapeutics and Celsion Corporation - Low Valuations Spark Investor Enthusiasm

11/22/2011 by Marketwire

Cardium Presents Third Quarter 2011 Financial Results and Reports on Near-Term Milestones

11/14/2011 by PR Newswire

Faster FDA Drug Reviews Should Benefit Cardium Therapeutics and CytRx Corporation

11/2/2011 by StockWatch
See More Articles...